nodes	percent_of_prediction	percent_of_DWPC	metapath
Vandetanib—YES1—IgA glomerulonephritis	0.615	0.933	CbGaD
Vandetanib—ALB—IgA glomerulonephritis	0.0441	0.0669	CbGaD
Vandetanib—FMO3—urine—IgA glomerulonephritis	0.00592	0.0708	CbGeAlD
Vandetanib—BLK—lymphoid tissue—IgA glomerulonephritis	0.00249	0.0298	CbGeAlD
Vandetanib—PLK4—lymphoid tissue—IgA glomerulonephritis	0.00195	0.0233	CbGeAlD
Vandetanib—RIPK2—nephron tubule—IgA glomerulonephritis	0.00186	0.0222	CbGeAlD
Vandetanib—Bosutinib—TLK1—IgA glomerulonephritis	0.00186	0.255	CrCbGaD
Vandetanib—VEGFA—nephron tubule—IgA glomerulonephritis	0.00185	0.0222	CbGeAlD
Vandetanib—FMO1—nephron tubule—IgA glomerulonephritis	0.00184	0.022	CbGeAlD
Vandetanib—TYRO3—lymphoid tissue—IgA glomerulonephritis	0.00183	0.0218	CbGeAlD
Vandetanib—LYN—lymphoid tissue—IgA glomerulonephritis	0.00182	0.0217	CbGeAlD
Vandetanib—ERBB3—nephron tubule—IgA glomerulonephritis	0.00178	0.0213	CbGeAlD
Vandetanib—FMO1—kidney—IgA glomerulonephritis	0.00162	0.0194	CbGeAlD
Vandetanib—FLT4—cortex of kidney—IgA glomerulonephritis	0.0016	0.0191	CbGeAlD
Vandetanib—VEGFA—cortex of kidney—IgA glomerulonephritis	0.00159	0.019	CbGeAlD
Vandetanib—SLK—nephron tubule—IgA glomerulonephritis	0.00158	0.0189	CbGeAlD
Vandetanib—FMO1—cortex of kidney—IgA glomerulonephritis	0.00158	0.0189	CbGeAlD
Vandetanib—ERBB3—kidney—IgA glomerulonephritis	0.00156	0.0187	CbGeAlD
Vandetanib—FLT3—lymphoid tissue—IgA glomerulonephritis	0.00155	0.0186	CbGeAlD
Vandetanib—CYP3A4—urine—IgA glomerulonephritis	0.00155	0.0185	CbGeAlD
Vandetanib—FYN—nephron tubule—IgA glomerulonephritis	0.00154	0.0184	CbGeAlD
Vandetanib—RET—kidney—IgA glomerulonephritis	0.00145	0.0173	CbGeAlD
Vandetanib—MKNK1—cortex of kidney—IgA glomerulonephritis	0.00143	0.0171	CbGeAlD
Vandetanib—FLT4—lymphoid tissue—IgA glomerulonephritis	0.00141	0.0169	CbGeAlD
Vandetanib—AXL—cortex of kidney—IgA glomerulonephritis	0.00141	0.0168	CbGeAlD
Vandetanib—YES1—nephron tubule—IgA glomerulonephritis	0.00139	0.0166	CbGeAlD
Vandetanib—IRAK4—lymphoid tissue—IgA glomerulonephritis	0.00137	0.0164	CbGeAlD
Vandetanib—SLK—cortex of kidney—IgA glomerulonephritis	0.00135	0.0162	CbGeAlD
Vandetanib—FYN—kidney—IgA glomerulonephritis	0.00135	0.0162	CbGeAlD
Vandetanib—ERBB3—lymphoid tissue—IgA glomerulonephritis	0.00134	0.0161	CbGeAlD
Vandetanib—TEK—kidney—IgA glomerulonephritis	0.00132	0.0158	CbGeAlD
Vandetanib—FYN—cortex of kidney—IgA glomerulonephritis	0.00132	0.0157	CbGeAlD
Vandetanib—Bosutinib—YES1—IgA glomerulonephritis	0.00129	0.177	CrCbGaD
Vandetanib—TEK—cortex of kidney—IgA glomerulonephritis	0.00129	0.0154	CbGeAlD
Vandetanib—MAP4K5—cortex of kidney—IgA glomerulonephritis	0.00129	0.0154	CbGeAlD
Vandetanib—MKNK1—lymphoid tissue—IgA glomerulonephritis	0.00126	0.0151	CbGeAlD
Vandetanib—RET—lymphoid tissue—IgA glomerulonephritis	0.00125	0.0149	CbGeAlD
Vandetanib—FGR—lymphoid tissue—IgA glomerulonephritis	0.00125	0.0149	CbGeAlD
Vandetanib—AXL—lymphoid tissue—IgA glomerulonephritis	0.00124	0.0148	CbGeAlD
Vandetanib—EPHB6—cortex of kidney—IgA glomerulonephritis	0.00123	0.0147	CbGeAlD
Vandetanib—KDR—nephron tubule—IgA glomerulonephritis	0.00123	0.0147	CbGeAlD
Vandetanib—YES1—kidney—IgA glomerulonephritis	0.00122	0.0146	CbGeAlD
Vandetanib—STK10—kidney—IgA glomerulonephritis	0.00121	0.0145	CbGeAlD
Vandetanib—Bosutinib—BTK—IgA glomerulonephritis	0.0012	0.164	CrCbGaD
Vandetanib—YES1—cortex of kidney—IgA glomerulonephritis	0.00119	0.0142	CbGeAlD
Vandetanib—SRC—kidney—IgA glomerulonephritis	0.00117	0.014	CbGeAlD
Vandetanib—FYN—lymphoid tissue—IgA glomerulonephritis	0.00116	0.0139	CbGeAlD
Vandetanib—MAP4K5—lymphoid tissue—IgA glomerulonephritis	0.00114	0.0136	CbGeAlD
Vandetanib—TEK—lymphoid tissue—IgA glomerulonephritis	0.00114	0.0136	CbGeAlD
Vandetanib—KDR—kidney—IgA glomerulonephritis	0.00108	0.0129	CbGeAlD
Vandetanib—Bosutinib—MAP3K7—IgA glomerulonephritis	0.00107	0.146	CrCbGaD
Vandetanib—MAP2K5—cortex of kidney—IgA glomerulonephritis	0.00105	0.0126	CbGeAlD
Vandetanib—KDR—cortex of kidney—IgA glomerulonephritis	0.00105	0.0126	CbGeAlD
Vandetanib—YES1—lymphoid tissue—IgA glomerulonephritis	0.00105	0.0125	CbGeAlD
Vandetanib—STK10—lymphoid tissue—IgA glomerulonephritis	0.00104	0.0124	CbGeAlD
Vandetanib—Bosutinib—MERTK—IgA glomerulonephritis	0.00102	0.14	CrCbGaD
Vandetanib—SRC—lymphoid tissue—IgA glomerulonephritis	0.00101	0.0121	CbGeAlD
Vandetanib—ABL1—nephron tubule—IgA glomerulonephritis	0.000948	0.0113	CbGeAlD
Vandetanib—PDGFRB—kidney—IgA glomerulonephritis	0.000935	0.0112	CbGeAlD
Vandetanib—KDR—lymphoid tissue—IgA glomerulonephritis	0.000928	0.0111	CbGeAlD
Vandetanib—PDGFRB—cortex of kidney—IgA glomerulonephritis	0.000911	0.0109	CbGeAlD
Vandetanib—ABL1—kidney—IgA glomerulonephritis	0.000833	0.00996	CbGeAlD
Vandetanib—ABL1—cortex of kidney—IgA glomerulonephritis	0.000812	0.0097	CbGeAlD
Vandetanib—PDGFRB—lymphoid tissue—IgA glomerulonephritis	0.000803	0.0096	CbGeAlD
Vandetanib—ABL1—lymphoid tissue—IgA glomerulonephritis	0.000716	0.00855	CbGeAlD
Vandetanib—ABCC1—cortex of kidney—IgA glomerulonephritis	0.000618	0.00739	CbGeAlD
Vandetanib—Bosutinib—CSF1R—IgA glomerulonephritis	0.000613	0.0841	CrCbGaD
Vandetanib—ABCG2—nephron tubule—IgA glomerulonephritis	0.000598	0.00715	CbGeAlD
Vandetanib—CYP3A4—kidney—IgA glomerulonephritis	0.000366	0.00437	CbGeAlD
Vandetanib—Erlotinib—ALB—IgA glomerulonephritis	0.00015	0.0206	CrCbGaD
Vandetanib—Gefitinib—ALB—IgA glomerulonephritis	9.39e-05	0.0129	CrCbGaD
Vandetanib—LYN—Signaling Pathways—AGT—IgA glomerulonephritis	1.86e-06	7.45e-06	CbGpPWpGaD
Vandetanib—LCK—Hemostasis—PIK3CA—IgA glomerulonephritis	1.86e-06	7.44e-06	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—RHOA—IgA glomerulonephritis	1.85e-06	7.41e-06	CbGpPWpGaD
Vandetanib—SRC—Immune System—CD80—IgA glomerulonephritis	1.85e-06	7.41e-06	CbGpPWpGaD
Vandetanib—ABCC1—Disease—SERPINE1—IgA glomerulonephritis	1.84e-06	7.38e-06	CbGpPWpGaD
Vandetanib—YES1—Immune System—MAPK1—IgA glomerulonephritis	1.83e-06	7.36e-06	CbGpPWpGaD
Vandetanib—PDGFRB—Disease—CD4—IgA glomerulonephritis	1.83e-06	7.35e-06	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—AGT—IgA glomerulonephritis	1.83e-06	7.33e-06	CbGpPWpGaD
Vandetanib—ERBB3—Immune System—PIK3CA—IgA glomerulonephritis	1.81e-06	7.27e-06	CbGpPWpGaD
Vandetanib—SRC—Adaptive Immune System—NRAS—IgA glomerulonephritis	1.8e-06	7.2e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—IQGAP1—IgA glomerulonephritis	1.79e-06	7.19e-06	CbGpPWpGaD
Vandetanib—FMO3—Metabolism—PIK3CA—IgA glomerulonephritis	1.78e-06	7.16e-06	CbGpPWpGaD
Vandetanib—ABCC1—Disease—RHOA—IgA glomerulonephritis	1.78e-06	7.12e-06	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—VAV3—IgA glomerulonephritis	1.77e-06	7.11e-06	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—YWHAZ—IgA glomerulonephritis	1.77e-06	7.1e-06	CbGpPWpGaD
Vandetanib—FYN—Disease—CD4—IgA glomerulonephritis	1.77e-06	7.08e-06	CbGpPWpGaD
Vandetanib—ABCG2—Metabolism—AGT—IgA glomerulonephritis	1.76e-06	7.08e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—HPSE—IgA glomerulonephritis	1.76e-06	7.05e-06	CbGpPWpGaD
Vandetanib—EGFR—Disease—SERPINE1—IgA glomerulonephritis	1.74e-06	6.96e-06	CbGpPWpGaD
Vandetanib—MAP2K5—Signaling Pathways—MMP9—IgA glomerulonephritis	1.73e-06	6.95e-06	CbGpPWpGaD
Vandetanib—EGFR—Innate Immune System—PIK3CA—IgA glomerulonephritis	1.73e-06	6.95e-06	CbGpPWpGaD
Vandetanib—MAP2K5—Signaling Pathways—PTEN—IgA glomerulonephritis	1.72e-06	6.91e-06	CbGpPWpGaD
Vandetanib—PDGFRB—Immune System—PTEN—IgA glomerulonephritis	1.72e-06	6.89e-06	CbGpPWpGaD
Vandetanib—EGFR—Immune System—IFNG—IgA glomerulonephritis	1.71e-06	6.86e-06	CbGpPWpGaD
Vandetanib—SRC—Disease—CD80—IgA glomerulonephritis	1.71e-06	6.84e-06	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—YWHAZ—IgA glomerulonephritis	1.71e-06	6.84e-06	CbGpPWpGaD
Vandetanib—SRC—Innate Immune System—MAPK1—IgA glomerulonephritis	1.7e-06	6.83e-06	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—CCR5—IgA glomerulonephritis	1.7e-06	6.82e-06	CbGpPWpGaD
Vandetanib—ALB—Metabolism—CD44—IgA glomerulonephritis	1.69e-06	6.78e-06	CbGpPWpGaD
Vandetanib—KDR—Signaling Pathways—MMP9—IgA glomerulonephritis	1.69e-06	6.78e-06	CbGpPWpGaD
Vandetanib—LYN—Immune System—PTEN—IgA glomerulonephritis	1.68e-06	6.75e-06	CbGpPWpGaD
Vandetanib—RIPK2—Signaling Pathways—NRAS—IgA glomerulonephritis	1.68e-06	6.74e-06	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—CD80—IgA glomerulonephritis	1.68e-06	6.74e-06	CbGpPWpGaD
Vandetanib—KDR—Signaling Pathways—PTEN—IgA glomerulonephritis	1.68e-06	6.74e-06	CbGpPWpGaD
Vandetanib—ABL1—Immune System—PTEN—IgA glomerulonephritis	1.67e-06	6.72e-06	CbGpPWpGaD
Vandetanib—ERBB3—Disease—PIK3CA—IgA glomerulonephritis	1.67e-06	6.71e-06	CbGpPWpGaD
Vandetanib—EGFR—Disease—RHOA—IgA glomerulonephritis	1.67e-06	6.71e-06	CbGpPWpGaD
Vandetanib—LCK—Disease—SERPINE1—IgA glomerulonephritis	1.67e-06	6.7e-06	CbGpPWpGaD
Vandetanib—ERBB3—Signaling Pathways—MMP9—IgA glomerulonephritis	1.67e-06	6.7e-06	CbGpPWpGaD
Vandetanib—LCK—Innate Immune System—PIK3CA—IgA glomerulonephritis	1.67e-06	6.7e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—UCP2—IgA glomerulonephritis	1.67e-06	6.68e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—HMMR—IgA glomerulonephritis	1.67e-06	6.68e-06	CbGpPWpGaD
Vandetanib—EGFR—Adaptive Immune System—PIK3CA—IgA glomerulonephritis	1.66e-06	6.67e-06	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—C3—IgA glomerulonephritis	1.66e-06	6.67e-06	CbGpPWpGaD
Vandetanib—ERBB3—Signaling Pathways—PTEN—IgA glomerulonephritis	1.66e-06	6.66e-06	CbGpPWpGaD
Vandetanib—FYN—Immune System—PTEN—IgA glomerulonephritis	1.66e-06	6.64e-06	CbGpPWpGaD
Vandetanib—EGFR—Immune System—CD4—IgA glomerulonephritis	1.65e-06	6.63e-06	CbGpPWpGaD
Vandetanib—LCK—Immune System—IFNG—IgA glomerulonephritis	1.65e-06	6.61e-06	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—CD80—IgA glomerulonephritis	1.65e-06	6.6e-06	CbGpPWpGaD
Vandetanib—SRC—Hemostasis—PIK3CA—IgA glomerulonephritis	1.64e-06	6.59e-06	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—CCR5—IgA glomerulonephritis	1.64e-06	6.58e-06	CbGpPWpGaD
Vandetanib—ALB—Metabolism—ABCA1—IgA glomerulonephritis	1.62e-06	6.5e-06	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—CD80—IgA glomerulonephritis	1.62e-06	6.5e-06	CbGpPWpGaD
Vandetanib—ABCC1—Disease—CD4—IgA glomerulonephritis	1.62e-06	6.49e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—ACSL1—IgA glomerulonephritis	1.61e-06	6.47e-06	CbGpPWpGaD
Vandetanib—LCK—Disease—RHOA—IgA glomerulonephritis	1.61e-06	6.47e-06	CbGpPWpGaD
Vandetanib—LCK—Adaptive Immune System—PIK3CA—IgA glomerulonephritis	1.6e-06	6.43e-06	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—C3—IgA glomerulonephritis	1.6e-06	6.43e-06	CbGpPWpGaD
Vandetanib—LCK—Immune System—CD4—IgA glomerulonephritis	1.59e-06	6.39e-06	CbGpPWpGaD
Vandetanib—YES1—Immune System—PIK3CA—IgA glomerulonephritis	1.59e-06	6.38e-06	CbGpPWpGaD
Vandetanib—PDGFRB—Disease—PTEN—IgA glomerulonephritis	1.59e-06	6.36e-06	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—AGT—IgA glomerulonephritis	1.58e-06	6.34e-06	CbGpPWpGaD
Vandetanib—RIPK2—Signaling Pathways—TGFB1—IgA glomerulonephritis	1.56e-06	6.27e-06	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—CCL2—IgA glomerulonephritis	1.56e-06	6.27e-06	CbGpPWpGaD
Vandetanib—ABCC1—Metabolism—ALB—IgA glomerulonephritis	1.54e-06	6.17e-06	CbGpPWpGaD
Vandetanib—MAP2K5—Signaling Pathways—NRAS—IgA glomerulonephritis	1.54e-06	6.17e-06	CbGpPWpGaD
Vandetanib—PDGFRB—Immune System—NRAS—IgA glomerulonephritis	1.53e-06	6.15e-06	CbGpPWpGaD
Vandetanib—RIPK2—Signaling Pathways—MAPK1—IgA glomerulonephritis	1.53e-06	6.15e-06	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—CCL2—IgA glomerulonephritis	1.53e-06	6.14e-06	CbGpPWpGaD
Vandetanib—FYN—Disease—PTEN—IgA glomerulonephritis	1.53e-06	6.13e-06	CbGpPWpGaD
Vandetanib—EGFR—Disease—CD4—IgA glomerulonephritis	1.53e-06	6.12e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—TBL1XR1—IgA glomerulonephritis	1.52e-06	6.11e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—SEC23A—IgA glomerulonephritis	1.52e-06	6.11e-06	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—AGT—IgA glomerulonephritis	1.52e-06	6.11e-06	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—MMP9—IgA glomerulonephritis	1.52e-06	6.09e-06	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—PTEN—IgA glomerulonephritis	1.51e-06	6.06e-06	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—YWHAZ—IgA glomerulonephritis	1.51e-06	6.05e-06	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—CCL2—IgA glomerulonephritis	1.51e-06	6.04e-06	CbGpPWpGaD
Vandetanib—LYN—Immune System—NRAS—IgA glomerulonephritis	1.5e-06	6.02e-06	CbGpPWpGaD
Vandetanib—KDR—Signaling Pathways—NRAS—IgA glomerulonephritis	1.5e-06	6.01e-06	CbGpPWpGaD
Vandetanib—ABL1—Immune System—NRAS—IgA glomerulonephritis	1.49e-06	5.99e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—ALOX5AP—IgA glomerulonephritis	1.49e-06	5.96e-06	CbGpPWpGaD
Vandetanib—ERBB3—Signaling Pathways—NRAS—IgA glomerulonephritis	1.48e-06	5.95e-06	CbGpPWpGaD
Vandetanib—SRC—Disease—SERPINE1—IgA glomerulonephritis	1.48e-06	5.94e-06	CbGpPWpGaD
Vandetanib—SRC—Innate Immune System—PIK3CA—IgA glomerulonephritis	1.48e-06	5.93e-06	CbGpPWpGaD
Vandetanib—FYN—Immune System—NRAS—IgA glomerulonephritis	1.48e-06	5.93e-06	CbGpPWpGaD
Vandetanib—LCK—Disease—CD4—IgA glomerulonephritis	1.47e-06	5.9e-06	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—MMP9—IgA glomerulonephritis	1.47e-06	5.88e-06	CbGpPWpGaD
Vandetanib—SRC—Immune System—IFNG—IgA glomerulonephritis	1.46e-06	5.86e-06	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—SERPINE1—IgA glomerulonephritis	1.46e-06	5.85e-06	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—PTEN—IgA glomerulonephritis	1.46e-06	5.85e-06	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—CCR5—IgA glomerulonephritis	1.45e-06	5.82e-06	CbGpPWpGaD
Vandetanib—ALB—Metabolism of lipids and lipoproteins—PTEN—IgA glomerulonephritis	1.43e-06	5.74e-06	CbGpPWpGaD
Vandetanib—EGFR—Immune System—PTEN—IgA glomerulonephritis	1.43e-06	5.74e-06	CbGpPWpGaD
Vandetanib—MAP2K5—Signaling Pathways—TGFB1—IgA glomerulonephritis	1.43e-06	5.73e-06	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—SERPINE1—IgA glomerulonephritis	1.43e-06	5.73e-06	CbGpPWpGaD
Vandetanib—SRC—Disease—RHOA—IgA glomerulonephritis	1.43e-06	5.73e-06	CbGpPWpGaD
Vandetanib—SRC—Adaptive Immune System—PIK3CA—IgA glomerulonephritis	1.42e-06	5.69e-06	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—C3—IgA glomerulonephritis	1.42e-06	5.69e-06	CbGpPWpGaD
Vandetanib—PDGFRB—Disease—NRAS—IgA glomerulonephritis	1.42e-06	5.68e-06	CbGpPWpGaD
Vandetanib—SRC—Immune System—CD4—IgA glomerulonephritis	1.41e-06	5.66e-06	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—RHOA—IgA glomerulonephritis	1.41e-06	5.64e-06	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—SERPINE1—IgA glomerulonephritis	1.41e-06	5.64e-06	CbGpPWpGaD
Vandetanib—ALB—Hemostasis—NRAS—IgA glomerulonephritis	1.4e-06	5.62e-06	CbGpPWpGaD
Vandetanib—ABCC1—Disease—PTEN—IgA glomerulonephritis	1.4e-06	5.62e-06	CbGpPWpGaD
Vandetanib—MAP2K5—Signaling Pathways—MAPK1—IgA glomerulonephritis	1.4e-06	5.62e-06	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—CD80—IgA glomerulonephritis	1.4e-06	5.61e-06	CbGpPWpGaD
Vandetanib—EGFR—Signaling by GPCR—NRAS—IgA glomerulonephritis	1.4e-06	5.6e-06	CbGpPWpGaD
Vandetanib—PDGFRB—Immune System—MAPK1—IgA glomerulonephritis	1.4e-06	5.6e-06	CbGpPWpGaD
Vandetanib—KDR—Signaling Pathways—TGFB1—IgA glomerulonephritis	1.39e-06	5.59e-06	CbGpPWpGaD
Vandetanib—ALB—Metabolism—HMOX1—IgA glomerulonephritis	1.39e-06	5.58e-06	CbGpPWpGaD
Vandetanib—LCK—Immune System—PTEN—IgA glomerulonephritis	1.38e-06	5.53e-06	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—RHOA—IgA glomerulonephritis	1.38e-06	5.53e-06	CbGpPWpGaD
Vandetanib—ERBB3—Signaling Pathways—TGFB1—IgA glomerulonephritis	1.38e-06	5.52e-06	CbGpPWpGaD
Vandetanib—LYN—Immune System—MAPK1—IgA glomerulonephritis	1.37e-06	5.49e-06	CbGpPWpGaD
Vandetanib—KDR—Signaling Pathways—MAPK1—IgA glomerulonephritis	1.37e-06	5.48e-06	CbGpPWpGaD
Vandetanib—FYN—Disease—NRAS—IgA glomerulonephritis	1.36e-06	5.47e-06	CbGpPWpGaD
Vandetanib—ABL1—Immune System—MAPK1—IgA glomerulonephritis	1.36e-06	5.46e-06	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—RHOA—IgA glomerulonephritis	1.36e-06	5.44e-06	CbGpPWpGaD
Vandetanib—ABCG2—Metabolism—ALB—IgA glomerulonephritis	1.35e-06	5.43e-06	CbGpPWpGaD
Vandetanib—ERBB3—Signaling Pathways—MAPK1—IgA glomerulonephritis	1.35e-06	5.42e-06	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—CD80—IgA glomerulonephritis	1.35e-06	5.41e-06	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—AGT—IgA glomerulonephritis	1.35e-06	5.41e-06	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—NRAS—IgA glomerulonephritis	1.35e-06	5.4e-06	CbGpPWpGaD
Vandetanib—FYN—Immune System—MAPK1—IgA glomerulonephritis	1.35e-06	5.4e-06	CbGpPWpGaD
Vandetanib—RIPK2—Signaling Pathways—PIK3CA—IgA glomerulonephritis	1.33e-06	5.33e-06	CbGpPWpGaD
Vandetanib—EGFR—Disease—PTEN—IgA glomerulonephritis	1.32e-06	5.3e-06	CbGpPWpGaD
Vandetanib—PDGFRB—Disease—TGFB1—IgA glomerulonephritis	1.32e-06	5.27e-06	CbGpPWpGaD
Vandetanib—ALB—Metabolism—TYMS—IgA glomerulonephritis	1.31e-06	5.26e-06	CbGpPWpGaD
Vandetanib—ALB—Hemostasis—TGFB1—IgA glomerulonephritis	1.3e-06	5.23e-06	CbGpPWpGaD
Vandetanib—SRC—Disease—CD4—IgA glomerulonephritis	1.3e-06	5.22e-06	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—NRAS—IgA glomerulonephritis	1.3e-06	5.22e-06	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—CCL2—IgA glomerulonephritis	1.3e-06	5.22e-06	CbGpPWpGaD
Vandetanib—PDGFRB—Disease—MAPK1—IgA glomerulonephritis	1.29e-06	5.17e-06	CbGpPWpGaD
Vandetanib—ALB—Hemostasis—MAPK1—IgA glomerulonephritis	1.28e-06	5.13e-06	CbGpPWpGaD
Vandetanib—EGFR—Immune System—NRAS—IgA glomerulonephritis	1.28e-06	5.12e-06	CbGpPWpGaD
Vandetanib—EGFR—Signaling by GPCR—MAPK1—IgA glomerulonephritis	1.27e-06	5.11e-06	CbGpPWpGaD
Vandetanib—LCK—Disease—PTEN—IgA glomerulonephritis	1.27e-06	5.11e-06	CbGpPWpGaD
Vandetanib—FYN—Disease—TGFB1—IgA glomerulonephritis	1.27e-06	5.08e-06	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—CCL2—IgA glomerulonephritis	1.25e-06	5.03e-06	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—TGFB1—IgA glomerulonephritis	1.25e-06	5.02e-06	CbGpPWpGaD
Vandetanib—ABCC1—Disease—NRAS—IgA glomerulonephritis	1.25e-06	5.02e-06	CbGpPWpGaD
Vandetanib—FYN—Disease—MAPK1—IgA glomerulonephritis	1.24e-06	4.99e-06	CbGpPWpGaD
Vandetanib—LCK—Immune System—NRAS—IgA glomerulonephritis	1.23e-06	4.93e-06	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—MAPK1—IgA glomerulonephritis	1.23e-06	4.92e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—RRM2—IgA glomerulonephritis	1.22e-06	4.91e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—GNG12—IgA glomerulonephritis	1.22e-06	4.91e-06	CbGpPWpGaD
Vandetanib—SRC—Immune System—PTEN—IgA glomerulonephritis	1.22e-06	4.9e-06	CbGpPWpGaD
Vandetanib—MAP2K5—Signaling Pathways—PIK3CA—IgA glomerulonephritis	1.22e-06	4.88e-06	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—SERPINE1—IgA glomerulonephritis	1.22e-06	4.87e-06	CbGpPWpGaD
Vandetanib—PDGFRB—Immune System—PIK3CA—IgA glomerulonephritis	1.21e-06	4.86e-06	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—TGFB1—IgA glomerulonephritis	1.21e-06	4.85e-06	CbGpPWpGaD
Vandetanib—ALB—Metabolism—CD36—IgA glomerulonephritis	1.21e-06	4.85e-06	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—CD80—IgA glomerulonephritis	1.19e-06	4.79e-06	CbGpPWpGaD
Vandetanib—LYN—Immune System—PIK3CA—IgA glomerulonephritis	1.19e-06	4.76e-06	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—MAPK1—IgA glomerulonephritis	1.19e-06	4.76e-06	CbGpPWpGaD
Vandetanib—KDR—Signaling Pathways—PIK3CA—IgA glomerulonephritis	1.19e-06	4.75e-06	CbGpPWpGaD
Vandetanib—ABL1—Immune System—PIK3CA—IgA glomerulonephritis	1.18e-06	4.74e-06	CbGpPWpGaD
Vandetanib—EGFR—Disease—NRAS—IgA glomerulonephritis	1.18e-06	4.73e-06	CbGpPWpGaD
Vandetanib—ABCC1—Metabolism—PTEN—IgA glomerulonephritis	1.17e-06	4.71e-06	CbGpPWpGaD
Vandetanib—ERBB3—Signaling Pathways—PIK3CA—IgA glomerulonephritis	1.17e-06	4.7e-06	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—RHOA—IgA glomerulonephritis	1.17e-06	4.7e-06	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—SERPINE1—IgA glomerulonephritis	1.17e-06	4.7e-06	CbGpPWpGaD
Vandetanib—FYN—Immune System—PIK3CA—IgA glomerulonephritis	1.17e-06	4.69e-06	CbGpPWpGaD
Vandetanib—EGFR—Immune System—MAPK1—IgA glomerulonephritis	1.16e-06	4.67e-06	CbGpPWpGaD
Vandetanib—ABCC1—Disease—TGFB1—IgA glomerulonephritis	1.16e-06	4.66e-06	CbGpPWpGaD
Vandetanib—ABCC1—Disease—MAPK1—IgA glomerulonephritis	1.14e-06	4.57e-06	CbGpPWpGaD
Vandetanib—LCK—Disease—NRAS—IgA glomerulonephritis	1.14e-06	4.56e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—NAMPT—IgA glomerulonephritis	1.13e-06	4.54e-06	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—RHOA—IgA glomerulonephritis	1.13e-06	4.53e-06	CbGpPWpGaD
Vandetanib—SRC—Disease—PTEN—IgA glomerulonephritis	1.13e-06	4.52e-06	CbGpPWpGaD
Vandetanib—LCK—Immune System—MAPK1—IgA glomerulonephritis	1.12e-06	4.5e-06	CbGpPWpGaD
Vandetanib—PDGFRB—Disease—PIK3CA—IgA glomerulonephritis	1.12e-06	4.49e-06	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—MMP9—IgA glomerulonephritis	1.12e-06	4.48e-06	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—PTEN—IgA glomerulonephritis	1.11e-06	4.46e-06	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—CCL2—IgA glomerulonephritis	1.11e-06	4.45e-06	CbGpPWpGaD
Vandetanib—ALB—Hemostasis—PIK3CA—IgA glomerulonephritis	1.11e-06	4.45e-06	CbGpPWpGaD
Vandetanib—EGFR—Signaling by GPCR—PIK3CA—IgA glomerulonephritis	1.11e-06	4.43e-06	CbGpPWpGaD
Vandetanib—EGFR—Disease—TGFB1—IgA glomerulonephritis	1.1e-06	4.39e-06	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—MMP9—IgA glomerulonephritis	1.09e-06	4.39e-06	CbGpPWpGaD
Vandetanib—SRC—Immune System—NRAS—IgA glomerulonephritis	1.09e-06	4.37e-06	CbGpPWpGaD
Vandetanib—ALB—Metabolism—AGT—IgA glomerulonephritis	1.09e-06	4.37e-06	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—PTEN—IgA glomerulonephritis	1.09e-06	4.36e-06	CbGpPWpGaD
Vandetanib—FYN—Disease—PIK3CA—IgA glomerulonephritis	1.08e-06	4.33e-06	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—MMP9—IgA glomerulonephritis	1.08e-06	4.32e-06	CbGpPWpGaD
Vandetanib—EGFR—Disease—MAPK1—IgA glomerulonephritis	1.07e-06	4.31e-06	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—PTEN—IgA glomerulonephritis	1.07e-06	4.29e-06	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—PIK3CA—IgA glomerulonephritis	1.07e-06	4.27e-06	CbGpPWpGaD
Vandetanib—LCK—Disease—TGFB1—IgA glomerulonephritis	1.06e-06	4.23e-06	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—SERPINE1—IgA glomerulonephritis	1.04e-06	4.16e-06	CbGpPWpGaD
Vandetanib—LCK—Disease—MAPK1—IgA glomerulonephritis	1.04e-06	4.15e-06	CbGpPWpGaD
Vandetanib—ABCG2—Metabolism—PTEN—IgA glomerulonephritis	1.03e-06	4.14e-06	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—PIK3CA—IgA glomerulonephritis	1.03e-06	4.13e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—PSME3—IgA glomerulonephritis	1.01e-06	4.07e-06	CbGpPWpGaD
Vandetanib—ALB—Metabolism of lipids and lipoproteins—PIK3CA—IgA glomerulonephritis	1.01e-06	4.05e-06	CbGpPWpGaD
Vandetanib—EGFR—Immune System—PIK3CA—IgA glomerulonephritis	1.01e-06	4.05e-06	CbGpPWpGaD
Vandetanib—SRC—Disease—NRAS—IgA glomerulonephritis	1.01e-06	4.03e-06	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—RHOA—IgA glomerulonephritis	1e-06	4.01e-06	CbGpPWpGaD
Vandetanib—SRC—Immune System—MAPK1—IgA glomerulonephritis	9.93e-07	3.98e-06	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—NRAS—IgA glomerulonephritis	9.91e-07	3.97e-06	CbGpPWpGaD
Vandetanib—ABCC1—Disease—PIK3CA—IgA glomerulonephritis	9.89e-07	3.97e-06	CbGpPWpGaD
Vandetanib—LCK—Immune System—PIK3CA—IgA glomerulonephritis	9.73e-07	3.9e-06	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—NRAS—IgA glomerulonephritis	9.71e-07	3.89e-06	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—NRAS—IgA glomerulonephritis	9.56e-07	3.83e-06	CbGpPWpGaD
Vandetanib—SRC—Disease—TGFB1—IgA glomerulonephritis	9.35e-07	3.75e-06	CbGpPWpGaD
Vandetanib—EGFR—Disease—PIK3CA—IgA glomerulonephritis	9.32e-07	3.74e-06	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—MMP9—IgA glomerulonephritis	9.31e-07	3.73e-06	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—PTEN—IgA glomerulonephritis	9.25e-07	3.71e-06	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—TGFB1—IgA glomerulonephritis	9.21e-07	3.69e-06	CbGpPWpGaD
Vandetanib—SRC—Disease—MAPK1—IgA glomerulonephritis	9.16e-07	3.67e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—CD44—IgA glomerulonephritis	9.13e-07	3.66e-06	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—MAPK1—IgA glomerulonephritis	9.03e-07	3.62e-06	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—TGFB1—IgA glomerulonephritis	9.02e-07	3.62e-06	CbGpPWpGaD
Vandetanib—LCK—Disease—PIK3CA—IgA glomerulonephritis	8.98e-07	3.6e-06	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—MMP9—IgA glomerulonephritis	8.97e-07	3.6e-06	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—PTEN—IgA glomerulonephritis	8.92e-07	3.58e-06	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—TGFB1—IgA glomerulonephritis	8.88e-07	3.56e-06	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—MAPK1—IgA glomerulonephritis	8.84e-07	3.55e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—ABCA1—IgA glomerulonephritis	8.76e-07	3.51e-06	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—MAPK1—IgA glomerulonephritis	8.71e-07	3.49e-06	CbGpPWpGaD
Vandetanib—SRC—Immune System—PIK3CA—IgA glomerulonephritis	8.61e-07	3.45e-06	CbGpPWpGaD
Vandetanib—ABCC1—Metabolism—PIK3CA—IgA glomerulonephritis	8.28e-07	3.32e-06	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—NRAS—IgA glomerulonephritis	8.26e-07	3.31e-06	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—NRAS—IgA glomerulonephritis	7.96e-07	3.19e-06	CbGpPWpGaD
Vandetanib—SRC—Disease—PIK3CA—IgA glomerulonephritis	7.95e-07	3.19e-06	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—MMP9—IgA glomerulonephritis	7.94e-07	3.18e-06	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—PTEN—IgA glomerulonephritis	7.89e-07	3.17e-06	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—PIK3CA—IgA glomerulonephritis	7.84e-07	3.14e-06	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—PIK3CA—IgA glomerulonephritis	7.67e-07	3.08e-06	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—TGFB1—IgA glomerulonephritis	7.67e-07	3.08e-06	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—PIK3CA—IgA glomerulonephritis	7.56e-07	3.03e-06	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—MAPK1—IgA glomerulonephritis	7.52e-07	3.02e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—HMOX1—IgA glomerulonephritis	7.51e-07	3.01e-06	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—TGFB1—IgA glomerulonephritis	7.39e-07	2.96e-06	CbGpPWpGaD
Vandetanib—ABCG2—Metabolism—PIK3CA—IgA glomerulonephritis	7.29e-07	2.92e-06	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—MAPK1—IgA glomerulonephritis	7.25e-07	2.91e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—TYMS—IgA glomerulonephritis	7.08e-07	2.84e-06	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—NRAS—IgA glomerulonephritis	7.04e-07	2.82e-06	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—TGFB1—IgA glomerulonephritis	6.54e-07	2.62e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—CD36—IgA glomerulonephritis	6.53e-07	2.62e-06	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—PIK3CA—IgA glomerulonephritis	6.53e-07	2.62e-06	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—MAPK1—IgA glomerulonephritis	6.42e-07	2.57e-06	CbGpPWpGaD
Vandetanib—ALB—Metabolism—PTEN—IgA glomerulonephritis	6.37e-07	2.56e-06	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—PIK3CA—IgA glomerulonephritis	6.29e-07	2.52e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—AGT—IgA glomerulonephritis	5.88e-07	2.36e-06	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—PIK3CA—IgA glomerulonephritis	5.57e-07	2.23e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—ALB—IgA glomerulonephritis	4.51e-07	1.81e-06	CbGpPWpGaD
Vandetanib—ALB—Metabolism—PIK3CA—IgA glomerulonephritis	4.5e-07	1.8e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—PTEN—IgA glomerulonephritis	3.44e-07	1.38e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—PIK3CA—IgA glomerulonephritis	2.43e-07	9.73e-07	CbGpPWpGaD
